Geode Capital Management
NVLN

Geode Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Geode Capital Management’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-84,353
Closed -$61K – 4309
2019
Q3 		$61K Sell
84,353
-1,056
-1% -$765 ﹤0.01% 4042
2019
Q2 		$66K Buy
85,409
+528
+0.6% +$587 ﹤0.01% 4042
2019
Q1 		$104K Buy
84,881
+1,980
+2% +$2.25K ﹤0.01% 3888
2018
Q4 		$71K Buy
82,901
+26,003
+46% +$29.4K ﹤0.01% 3926
2018
Q3 		$168K Buy
56,898
+1,473
+3% +$5.21K ﹤0.01% 3802
2018
Q2 		$203K Sell
55,425
-29,086
-34% -$117K ﹤0.01% 3716
2018
Q1 		$295K Buy
84,511
+6,157
+8% +$26.1K ﹤0.01% 3574
2017
Q4 		$244K Buy
78,354
+40,194
+105% +$193K ﹤0.01% 3618
2017
Q3 		$268K Buy
38,160
+12,438
+48% +$99.7K ﹤0.01% 3571
2017
Q2 		$237K Buy
+25,722
New +$248K ﹤0.01% 3619

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return